MicroTex
The EPSRC Research and Partnership Hub in Microscale Science and Technology to Accelerate Therapeutic Innovation.
MicroTex develops microscale technologies to improve how medicines, diagnostics, and medical devices are designed, tested, and translated into healthcare
What we do
Microscale Systems
Building technologies to study biological systems at small scale.
Therapeutic Development
Improving predictive and translational approaches for drug testing and delivery.
Biosensing and Diagnostics
Developing technologies for real-time biological monitoring and healthcare innovation.
A Collaborative Research Hub
A collaboration involving the University of Edinburgh, Heriot-Watt University, and the University of Bath, MicroTex brings together researchers, clinicians, engineers, and partners across disciplines to address key bottlenecks in therapeutic development.
By combining microscale science, translational research, and healthcare innovation, the Hub aims to improve the speed, precision, and reliability of how therapies are developed and tested.
Advancing microscale science for safer, faster, and more accessible therapeutic innovation.
The Impact of MicroTex
Faster Drug Development
Supporting earlier and more predictive therapeutic evaluation.
Human-Relevant Testing
Improving preclinical models and translational reliability.
Precision Therapeutics
Advancing targeted and controlled therapeutic approaches.
Interdisciplinary Innovation
Connecting engineering, biomedical science, and clinical research.
Better Patient Outcomes
Supporting safer and more effective therapies.
Our Vision
Our vision is to accelerate the development of safer, more effective therapies to improve global health outcomes.
Our Mission
Our mission is to transform outdated drug development systems through microscale innovation, enabling safer, faster, and more accessible therapeutic development worldwide.
Research Platforms
MicroTex research is organised into focused platforms that address key challenges in therapeutic development. These platforms bring together microscale science, engineering, and translational research to improve how diseases are studied and how new therapies are developed and tested.
Lung Platform
Focuses on respiratory disease, inflammation, infection, and challenges in accessing and treating the lung.
Eye Platform
Focuses on ocular disease, barriers to drug delivery, and challenges in treating the cornea
Why Does Therapeutic Innovation Require Collaboration?
Developing new therapies requires expertise across multiple disciplines. By combining strengths across these universities, MicroTex supports collaborative approaches to addressing complex therapeutic challenges and advancing translational research.
MicroTex brings together a broad, multidisciplinary team spanning engineering, biomedical science, clinical research, and translational healthcare.
Robotics
Chemistry
Engineering
